Skip to main content
Year archive

HYUNDAI PHARMACEUTICAL CO., LTD — 2024 filings

All 23 regulatory filings released by HYUNDAI PHARMACEUTICAL CO., LTD (004310) in 2024, sourced directly from the official regulator.

23 Filings
2024 Period
2024 filings (23)
Filing Released Lang
투자판단관련주요경영사항
Regulatory Filings
2024-12-31 Korean
투자판단관련주요경영사항
Regulatory Filings
2024-12-16 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2024-11-15 Korean
분기보고서 (2024.08)
Interim / Quarterly Report 9M 2024
2024-10-15 Korean
불성실공시법인지정
Regulatory Filings
2024-09-20 Korean
불성실공시법인지정예고
Regulatory Filings
2024-08-23 Korean
투자판단관련주요경영사항
Regulatory Filings
2024-08-20 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information
2024-07-12 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares
2024-07-12 Korean
신탁계약해지결과보고서
Transaction in Own Shares
2024-07-12 Korean
반기보고서 (2024.05)
Interim / Quarterly Report H1 2024
2024-07-12 Korean
투자판단관련주요경영사항
Regulatory Filings
2024-05-21 Korean
분기보고서 (2024.02)
Interim / Quarterly Report Q1 2024
2024-04-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2024-02-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2024-02-29 Korean
감사보고서제출
Audit Report / Information FY 2023
2024-02-21 Korean
사업보고서 (2023.11)
Audit Report / Information FY 2023
2024-02-21 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information
2024-02-13 Korean
주주총회소집결의
AGM Information
2024-02-13 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2024-02-13 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2024-02-13 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount
2024-02-13 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2023
2024-02-13 Korean